Currently out of the existing stock ratings of Andy Chen, 33 are a BUY (73.33%), 2 are a SELL (4.44%), 10 are a HOLD (22.22%).

Andy Chen

Work Performance Price Targets & Ratings Chart

Analyst Andy Chen, currently employed at WOLFE, has had 72.22% of price targets met with an average potential upside of 47.29%, reached in 217 days on average.

Andy Chen has documented 76 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSM, Insmed at 12-Oct-2026.

Wall Street Analyst Andy Chen

Analyst best performing recommendations are on ALPN (ALPINE IMMUNE SCIENCES).
The best stock recommendation documented was for ALPN (ALPINE IMMUNE SCIENCES) on 10/16/2023. The price target of $18 was fulfilled within 58 days with a profit of $8 (80%), with a performance score of 13.79.

Average potential price target upside

IMVT Immunovant INSM Insmed KYMR Kymera Therapeutics MDGL Madrigal Pharmaceuticals MLTX MoonLake Immunotherapeutics NTLA Intellia Therapeutics VERA Vera Therapeutics VRTX Vertex Pharmaceuticals ALPN Alpine Immune Sciences ALNY Alnylam Pharmaceuticals ROIV Roivant Sciences Ltd VRDN Viridian Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Jan-2026

$33

$1.23 (3.87%)

$30

11 days ago
(10-Nov-2026)

8/10 (80%)

$-2.71 (-7.59%)

239

Buy Since 24-Jul-2023

$47

$15.23 (47.94%)

$45

11 days ago
(10-Nov-2026)

8/13 (61.54%)

$11.29 (31.62%)

365

Buy Since 20-Feb-2024

$50

$18.23 (57.38%)

$35

3 months 17 days ago
(04-Aug-2026)

4/7 (57.14%)

$10.64 (27.03%)

207

Buy Since 25-Apr-2023

$61

$29.23 (92.01%)

$58

4 months 22 days ago
(30-Jun-2026)

2/8 (25%)

$22.47 (58.32%)

100

Buy Since 23-May-2023

$62

$30.23 (95.15%)

$44

5 months 26 days ago
(26-May-2026)

6/11 (54.55%)

$28.17 (83.27%)

217

Show more analysts

Please expand the browser size to see the chart

Which stock is Andy Chen most bullish on?

Potential upside of $225.9 has been obtained for MDGL (MADRIGAL PHARMACEUTICALS)

Which stock is Andy Chen most reserved on?

Potential downside of -$1 has been obtained for NTLA (INTELLIA THERAPEUTICS)

What Year was the first public recommendation made by Andy Chen?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?